These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


387 related items for PubMed ID: 16866718

  • 1. Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan.
    Goldstein J, Tiseo PT, Albert KS, Li C, Sikes CR.
    Headache; 2006; 46(7):1142-50. PubMed ID: 16866718
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial.
    Winner P, Linder SL, Lipton RB, Almas M, Parsons B, Pitman V.
    Headache; 2007 Apr; 47(4):511-8. PubMed ID: 17445100
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Early treatment of migraine with rizatriptan: a placebo-controlled study.
    Mathew NT, Kailasam J, Meadors L.
    Headache; 2004 Apr; 44(7):669-73. PubMed ID: 15209688
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Preference for rizatriptan 10-mg wafer vs. eletriptan 40-mg tablet for acute treatment of migraine.
    Láinez MJ, Evers S, Kinge E, Allais G, Allen C, Rao NA, Massaad R, Lis K.
    Cephalalgia; 2006 Mar; 26(3):246-56. PubMed ID: 16472330
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rizatriptan 10-mg wafer versus usual nontriptan therapy for migraine: analysis of return to function and patient preference.
    Pascual J, García-Moncó C, Roig C, Yusta Izquierdo A, López-Gil A, eMAX Study Group.
    Headache; 2005 Oct; 45(9):1140-50. PubMed ID: 16178944
    [Abstract] [Full Text] [Related]

  • 12. Predictors of migraine headache recurrence: a pooled analysis from the eletriptan database.
    Dodick DW, Lipton RB, Goadsby PJ, Tfelt-Hansen P, Ferrari MD, Diener HC, Almas M, Albert KS, Parsons B.
    Headache; 2008 Feb; 48(2):184-93. PubMed ID: 18234045
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine.
    Nett R, Mannix LK, Mueller L, Rodgers A, Hustad CM, Skobieranda F, Ramsey KE.
    Headache; 2008 Sep; 48(8):1194-201. PubMed ID: 18422606
    [Abstract] [Full Text] [Related]

  • 15. Comment on eletriptan in migraine patients reporting unsatisfactory response to rizatriptan.
    Rodgers A, Hustad CM, Ramsey KE, Skobieranda F.
    Headache; 2007 Mar; 47(3):452; author reply 452-3. PubMed ID: 17371373
    [No Abstract] [Full Text] [Related]

  • 16. Eletriptan treatment of migraine in patients switching from barbiturate-containing analgesics: results from a multiple-attack study.
    Martin VT, Loder E, Taylor K, Almas M, Hilliard B.
    Cephalalgia; 2005 Sep; 25(9):726-34. PubMed ID: 16109055
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies.
    Martin V, Cady R, Mauskop A, Seidman LS, Rodgers A, Hustad CM, Ramsey KE, Skobieranda F.
    Headache; 2008 Feb; 48(2):226-35. PubMed ID: 18005144
    [Abstract] [Full Text] [Related]

  • 18. Effects on productivity and quality of life of rizatriptan for acute migraine: a workplace study.
    Láinez MJ, López A, Pascual AM.
    Headache; 2005 Feb; 45(7):883-90. PubMed ID: 15985105
    [Abstract] [Full Text] [Related]

  • 19. Patient-reported benefits of rizatriptan compared with usual non-triptan therapy for migraine in a primary care setting.
    Baos V, Serrano A, Torrecilla M, Bertral C, Caloto MT, Nocea G, Gerth WC, I-MAX Study Group.
    Int J Clin Pract; 2003 Nov; 57(9):761-8. PubMed ID: 14686564
    [Abstract] [Full Text] [Related]

  • 20. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
    Mathew NT, Finlayson G, Smith TR, Cady RK, Adelman J, Mao L, Wright P, Greenberg SJ, AEGIS Investigator Study Group.
    Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.